Cargando…
Review of molecular biological research on the treatment of membranous nephropathy with Tripterygium glycosides based on TCM theory
To explore the mechanism of Tripterygium wilfordii polyglycoside (TWP) in the treatment of membranous nephropathy (MN) by network pharmacology. TCMSP and DrugBank databases were used to screen the main targets of the main active components of Tripterygium glycosides, and OMIM and Gene Cards database...
Autores principales: | Xu, Pengyu, Fu, Guangchu, Zhao, Haishen, Wang, Manya, Ye, Hong, Shi, Kejun, Zang, Pin, Su, Xubo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637535/ https://www.ncbi.nlm.nih.gov/pubmed/37960769 http://dx.doi.org/10.1097/MD.0000000000034686 |
Ejemplares similares
-
Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022) -
Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation
por: Gao, Ying, et al.
Publicado: (2021) -
The effect and safety of low-dose Tripterygium wilfordii in patients with type 2 diabetic nephropathy: A meta-analysis
por: Chen, Yixuan, et al.
Publicado: (2022) -
Clinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation
por: Wang, Jia, et al.
Publicado: (2015) -
Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study
por: Gu, Qiu-hua, et al.
Publicado: (2016)